Table 2.
COVID-19-related anamnesis of Algerian healthcare workers receiving COVID-19 vaccines (n = 721).
| Variable | Outcome |
Inactivated virus vaccine (n = 450) |
Adenoviral vector vaccine (n = 271) |
Total (n = 721) |
Sig. |
|---|---|---|---|---|---|
| Infection | Yes | 216 (48%) | 125 (45.6%) | 341 (47.1%) | 0.534 |
| No | 234 (52%) | 149 (54.4%) | 383 (52.9%) | ||
| Onset | Before vaccination | 197 (91.2%) | 112 (89.6%) | 309 (90.6%) | 0.625 |
| After second dose | 19 (8.8%) | 13 (10.4%) | 32 (9.4%) | ||
| Vaccination timing | Less than a week ago | 13 (2.9%) | 12 (4.4%) | 25 (3.5%) | 0.274 |
| From a week to a month ago | 64 (14.2%) | 43 (15.9%) | 107 (14.8%) | 0.547 | |
| From a month to 3 months ago | 187 (41.6%) | 56 (20.7%) | 243 (33.7%) | < 0.001 | |
| More than 3 months ago | 186 (41.3%) | 160 (59%) | 346 (48%) | < 0.001 | |
| Number of doses | One dose ‡ | 90 (20%) | 63 (24.8%) | 153 (21.7%) | 0.138 |
| Two doses | 360 (80%) | 191 (75.2%) | 551 (78.3%) |
‡
Chi-squared test (χ2) had been used with a significance level (Sig.) ≤ 0.05;, Participants who received Ad26.COV2.S were excluded.
Bold values refer to the statisitically signifcant values which are below 0.05.